Dibutyl Sebacate

Dibutyl Sebacate

SCHEMBL7768874

CCCCOC(=O)CCCCCCCCC(=O)OCCCC.CCOC(=O)c1ccccc1C(=O)OCC

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.69
TDP1 Q9NUW8 3/20 0.69
L3MBTL1 Q9Y468 3/20 0.69
ALDH1A1 P00352 7/20 0.65
LMNA P02545 1/20 0.65
CYP3A4 P08684 3/20 0.62
MAPK1 P28482 2/20 0.62
TP53 P04637 1/20 0.62
HSD17B10 Q99714 3/20 0.56
KDM4E B2RXH2 1/20 0.54
POLB P06746 1/20 0.54
DGKA P23743 1/20 0.53
PRSS1 P07477 1/20 0.48
PRSS2 P07478 1/20 0.48
PRSS3 P35030 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA2 P00918 1/20 0.47
CYP4F2 P78329 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Phthalate SCHEMBL28194307 0.96 ALDH1A1 (0.72) TSHRTDP1L3MBTL1ALDH1A1LMNA
Dibutyl Sebacate SCHEMBL5445113 0.94 TSHR (0.78) TSHRTDP1L3MBTL1ALDH1A1LMNA
Dibutyl Phthalate SCHEMBL8962381 0.94 TSHR (0.78) TSHRTDP1L3MBTL1ALDH1A1LMNA
Dibutyl Phthalate SCHEMBL11523616 0.92 TSHR (0.81) TSHRTDP1L3MBTL1ALDH1A1LMNA
Dibutyl Phthalate SCHEMBL10731020 0.91 ALDH1A1 (0.79) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL4255174 0.91 ALDH1A1 (0.79) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL28236934 0.91 ALDH1A1 (0.79) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL10355198 0.91 TSHR (0.78) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL28092209 0.90 ALDH1A1 (0.77) TSHRTDP1L3MBTL1ALDH1A1LMNA
SCHEMBL9298568 0.90 ALDH1A1 (0.82) TSHRTDP1L3MBTL1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10143659-B2 Melt-extruded release controlled pharmaceutical composition and oral dosage form comprising the same Samyang Biopharmaceutical Corporation (KR) 2018-12-04 US disclosed
EP-2939663-B1 MELT-EXTRUDED RELEASE CONTROLLED PHARMACEUTICAL COMPOSITION AND ORAL DOSAGE FROM COMPRISING THE SAME SAMYANG BIOPHARMACEUTICALS (KR) 2018-09-05 EP disclosed
US-20160213621-A1 Melt-Extruded Release Controlled Pharmaceutical Composition and Oral Dosage Form Comprising the Same SAMYANG HOLDINGS CORPORATION (KR) 2016-07-28 US disclosed
EP-2939663-A1 MELT EXTRUDED PHARMACEUTICAL COMPOSITION FOR CONTROLLING RELEASE, AND MEDICINE FOR ORAL ADMINISTRATION INCLUDING SAME Samyang Biopharmaceuticals Corporation (KR) 2015-11-04 EP disclosed
EP-1068276-A1 RF ACTIVE COMPOSITIONS FOR USE IN ADHESION, BONDING AND COATING Ameritherm, Inc. (US) 2001-01-17 EP disclosed
WO-1999047621-A9 RF ACTIVE COMPOSITIONS FOR USE IN ADHESION, BONDING AND COATING AMERITHERM INC (US) 1999-12-16 WO disclosed
WO-1999047621-A1 RF ACTIVE COMPOSITIONS FOR USE IN ADHESION, BONDING AND COATING AMERITHERM, INC. (US) 1999-09-23 WO disclosed